Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-04-26

FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)

View source ↗

Summary

FDA approved a supplemental application for Claritin (loratadine) by Bayer HealthCare LLC to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin (loratadine)

Snippet

SUPPL AP for CLARITIN (LORATADINE)